Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Investors |
Shareholder information
Minutes_Ordinary General Meeting_May 2024
Notice_Ordinary General Meeting_May 2024
Minutes_Extraordinary General Meeting_April 2024
Notice_Extraordinary General Meeting_April 2024
Minutes_Ordinary General Meeting_April 2023
Notice_Ordinary General Meeting_April 2023
Minutes_Ordinary General Meeting_April 2022
Notice_Ordinary General Meeting_April 2022
Minutes_Ordinary General Meeting_June 2021
National Prospectus_May 2021
investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024